Retatrutide for Weight Loss: What the Clinical Data Shows Retatrutide produced up to 24.2% mean body-weight reduction at 48 weeks in the highest-dose (12mg weekly) cohort of the phase 2 obesity trial published by Jastreboff and colleagues in the New England Journal of Medicine in 2023
This reduction in GPx and GST activities would lead to a decrease in GSH synthesis, which would affect many essential metabolic pathways in which GSH is involved
Some animal experiments also showcase a 54% increase in IGF-I and reduced loss of muscle strength loss in drug-induced catabolic conditions [18, 19]
Cloudiness usually indicates the peptide has degraded or the water used was not true bacteriostatic water
It targets people with diabetes and obesity, addressing both health issues together
Taking your injection at night, staying hydrated, eating small bland meals, and avoiding fatty foods minimizes discomfort